Mammography May Be Better Than MRI For Screening After Breast Cancer

Wednesday, April 29, 2015
Medscape (4/29, Harrison) reports that research suggests that “for women with a personal history of breast cancer, surveillance is better with mammography than with MRI because more cancers are detected with mammography in these patients.” The findings were presented at the American Roentgen Ray Society 2015 Annual Meeting. 

Molecular Imaging Allows Physicians To Precisely Target A Patient’s Specific Cancer Cells

Tuesday, April 28, 2015
In a 1,700-word article, the Washington Post (4/28, Kolatch) reports on “molecular imaging, an emerging technology that allows” physicians “to precisely target a patient’s specific cancer cells.” This “approach allows for a reduction in radiation and chemotherapy and the debilitating side effects that accompany them.” 

DBT May Provide Overall Greater Cancer Detection Than Digital Mammography In Women With Dense Breast Tissue

Saturday, April 25, 2015
Diagnostic Imaging (4/25) reported that research suggests that “digital breast tomosynthesis (DBT) provides overall greater cancer detection than digital mammography, especially among women with dense breast tissue.” The findings were presented at the American Roentgen Ray Society Annual Meeting. 

Rep. Wasserman Schultz Critical Of USPSTF’s Mammography Draft Recommendations

Friday, April 24, 2015
In the Washington Post (4/24) “To Your Health” blog, US Rep. Debbie Wasserman Schultz (D-FL) writes that the US Preventive Services Task Force’s mammography draft recommendations “could lead to insurance companies dropping coverage of mammograms for women under age 50, as well as other preventive techniques that would help protect young women from getting breast cancer and help those who do have it.” Rep. Wasserman Schultz writes, “I urge the USPSTF to reverse its recommendation and avoid the needless deaths that will inevitably result when women between 40 and 50 don’t get mammograms, believing that the experts said it would be unnecessary.” 

FDA Approves Siemens’ Tomosynthesis Add-On For Certain Digital Mammography Systems

Friday, April 24, 2015
HealthImaging (4/24) reports, “The FDA has approved the breast tomosynthesis add-on option for Siemens Healthcare’s MAMMOMAT Inspiration and MAMMOMAT Inspiration Prime Edition digital mammography systems.” Diagnostic Imaging (4/24) also covers the story.